{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:25:17Z","timestamp":1785522317280,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100016730","name":"Torii Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12325-026-03602-7","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:38:41Z","timestamp":1780115921000},"page":"3616-3632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of Mean Corpuscular Hemoglobin with Survival and Cardiovascular Outcomes Among Patients with Hemodialysis in Japan Based on Real-World Data"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9641-1055","authenticated-orcid":false,"given":"Keita","family":"Teruya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8700-8679","authenticated-orcid":false,"given":"Aya","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8897-8561","authenticated-orcid":false,"given":"Yuko","family":"Mitobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-6145","authenticated-orcid":false,"given":"Hirokazu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"11","key":"3602_CR1","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1093\/ndt\/gfn346","volume":"23","author":"T Akizawa","year":"2008","unstructured":"Akizawa T, Pisoni RL, Akiba T, et al. Japanese haemodialysis anaemia management practices and outcomes (1999\u20132006): results from the DOPPS. Nephrol Dial Transplant. 2008;23(11):3643\u201353.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"3602_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2215\/CJN.04950908","volume":"4","author":"RN Foley","year":"2009","unstructured":"Foley RN, Curtis BM, Parfrey PS. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol. 2009;4(4):726\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3602_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/kisup.2012.37","volume":"2","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Parfrey PS, Adamson JW, et al. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:279\u2013335.","journal-title":"Kidney Int Suppl"},{"key":"3602_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41100-017-0114-y","volume":"3","author":"H Yamamoto","year":"2017","unstructured":"Yamamoto H, Nishi S, Tomo T, et al. 2015 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther. 2017;3:36.","journal-title":"Ren Replace Ther"},{"issue":"3","key":"3602_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1681\/ASN.2007070728","volume":"20","author":"K Kalantar-Zadeh","year":"2009","unstructured":"Kalantar-Zadeh K, Aronoff GR. Hemoglobin variability in anemia of chronic kidney disease. J Am Soc Nephrol. 2009;20(3):479\u201387.","journal-title":"J Am Soc Nephrol"},{"issue":"18","key":"3602_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813779","volume":"24","author":"N Tomosugi","year":"2023","unstructured":"Tomosugi N, Koshino Y, Ogawa C, et al. Oral iron absorption of ferric citrate hydrate and hepcidin-25 in hemodialysis patients: a prospective, multicenter, observational Riona-Oral Iron Absorption Trial. Int J Mol Sci. 2023;24(18):13779.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3602_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10157-019-01791-w","volume":"24","author":"N Tomosugi","year":"2020","unstructured":"Tomosugi N, Koshino Y. Tips for erythropoiesis-stimulating agent treatment of renal anemia. Clin Exp Nephrol. 2020;24(1):105\u20136.","journal-title":"Clin Exp Nephrol"},{"key":"3602_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/925907","volume":"2011","author":"T Karlsson","year":"2011","unstructured":"Karlsson T. Comparative evaluation of the reticulocyte hemoglobin content assay when screening for iron deficiency in elderly anemic patients. Anemia. 2011;2011:925907.","journal-title":"Anemia"},{"issue":"9","key":"3602_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/jcp.2011.090514","volume":"64","author":"OM Jolobe","year":"2011","unstructured":"Jolobe OM. Mean corpuscular haemoglobin, referenced and resurrected. J Clin Pathol. 2011;64(9):833\u20134.","journal-title":"J Clin Pathol"},{"key":"3602_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/B978-1-4377-0974-2.00030-0","volume-title":"Henry\u2019s clinical diagnosis and management by laboratory methods","author":"N Vajpayee","year":"2011","unstructured":"Vajpayee N, Graham SS, Bem S. Basic examination of blood and bone marrow. In: McPherson RA, Pincus MR, editors. Henry\u2019s clinical diagnosis and management by laboratory methods. Philadelphia: Elsevier Saunders; 2011. p. 509\u201335."},{"issue":"4","key":"3602_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000502633","volume":"50","author":"T Hara","year":"2019","unstructured":"Hara T, Kimachi M, Ikenoue T, et al. Intra-dialytic hemoglobin changes and cardiovascular events: a cohort study on dialysis outcomes and practice patterns in Japan. Am J Nephrol. 2019;50(4):272\u201380.","journal-title":"Am J Nephrol"},{"issue":"3","key":"3602_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000495726","volume":"141","author":"A Dratch","year":"2019","unstructured":"Dratch A, Kleine CE, Streja E, et al. Mean corpuscular volume and mortality in incident hemodialysis patients. Nephron. 2019;141(3):188\u2013200.","journal-title":"Nephron"},{"issue":"1","key":"3602_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72765-2","volume":"10","author":"H Honda","year":"2020","unstructured":"Honda H, Kimachi M, Kurita N, et al. Low rather than high mean corpuscular volume is associated with mortality in Japanese patients under hemodialysis. Sci Rep. 2020;10(1):15663.","journal-title":"Sci Rep"},{"issue":"2","key":"3602_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.11648\/j.ijbecs.20200602.13","volume":"6","author":"Y Tsuji","year":"2020","unstructured":"Tsuji Y, Hitomi Y, Suzuki N, et al. Association between the distributions of mean corpuscular hemoglobin and red blood cell, and mortality in a 3-year retrospective study of hemodialysis patients. Int J Biomed Eng Clin Sci. 2020;6(2):41\u20137.","journal-title":"Int J Biomed Eng Clin Sci"},{"issue":"6","key":"3602_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ekir.2019.03.016","volume":"4","author":"HA Stirnadel-Farrant","year":"2019","unstructured":"Stirnadel-Farrant HA, Karaboyas A, Cizman B, et al. Cardiovascular event rates among hemodialysis patients across geographical regions-a snapshot from the dialysis outcomes and practice patterns study (DOPPS). Kidney Int Rep. 2019;4(6):864\u201372.","journal-title":"Kidney Int Rep"},{"key":"3602_CR16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.4236\/ajac.2014.514098","volume":"5","author":"X Long","year":"2014","unstructured":"Long X, Fang J, Yao L, et al. Correlation analysis between mean corpuscular hemoglobin and mean corpuscular volume for thalassemia screening in large population. Am J Analyt Chem. 2014;5:901\u20137.","journal-title":"Am J Analyt Chem"},{"issue":"10","key":"3602_CR17","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/ndt\/gft062","volume":"28","author":"GR Bailie","year":"2013","unstructured":"Bailie GR, Larkina M, Goodkin DA, et al. Variation in intravenous iron use internationally and over time: the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2013;28(10):2570\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"3602_CR18","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.2215\/CJN.00710111","volume":"6","author":"J Bazeley","year":"2011","unstructured":"Bazeley J, Bieber B, Li Y, et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(10):2452\u201361.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3602_CR19","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2215\/CJN.01070308","volume":"3","author":"M Rambod","year":"2008","unstructured":"Rambod M, Kovesdy CP, Kalantar-Zadeh K. Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. Clin J Am Soc Nephrol. 2008;3(6):1691\u2013701.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"3602_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.20452\/pamw.1458","volume":"122","author":"J Ma\u0142yszko","year":"2012","unstructured":"Ma\u0142yszko J, Koc-\u017b\u00f3rawska E, Levin-Iaina N, et al. New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis. Pol Arch Med Wewn. 2012;122(11):537\u201342.","journal-title":"Pol Arch Med Wewn"},{"issue":"9","key":"3602_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091173","volume":"10","author":"N Ueda","year":"2018","unstructured":"Ueda N, Takasawa K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients. 2018;10(9):1173.","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"3602_CR22","first-page":"S6","volume":"21","author":"S Dev","year":"2017","unstructured":"Dev S, Babitt JL. Overview of iron metabolism in health and disease. Hemodial Int. 2017;21(Suppl 1):S6\u201320.","journal-title":"Hemodial Int"},{"issue":"1","key":"3602_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circ. 2018;138(1):80\u201398.","journal-title":"Circ"},{"issue":"3","key":"3602_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173468","volume":"12","author":"Y Matsubara","year":"2017","unstructured":"Matsubara Y, Kimachi M, Fukuma S, et al. Development of a new risk model for predicting cardiovascular events among hemodialysis patients: population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS). PLoS ONE. 2017;12(3):e0173468.","journal-title":"PLoS ONE"},{"issue":"2","key":"3602_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/sdi.13181","volume":"37","author":"T Gan","year":"2024","unstructured":"Gan T, Guan H, Li P, et al. Risk prediction models for cardiovascular events in hemodialysis patients: a systematic review. Semin Dial. 2024;37(2):101\u20139.","journal-title":"Semin Dial"},{"issue":"4","key":"3602_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938\u201342.","journal-title":"Hypertension"},{"issue":"6","key":"3602_CR27","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ndt\/gfh217","volume":"19","author":"T Adragao","year":"2004","unstructured":"Adragao T, Pires A, Lucas C, et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1480\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3602_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.10909","volume":"6","author":"H Zhang","year":"2023","unstructured":"Zhang H, Li G, Yu X, et al. Progression of vascular calcification and clinical outcomes in patients receiving maintenance dialysis. JAMA Netw Open. 2023;6(5):e2310909.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"3602_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/CIRCRESAHA.119.316453","volume":"127","author":"X Tang","year":"2020","unstructured":"Tang X, Fang M, Cheng R, et al. Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability. Circ Res. 2020;127(5):651\u201363.","journal-title":"Circ Res"},{"issue":"4","key":"3602_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/colloids8040047","volume":"8","author":"G Barshtein","year":"2024","unstructured":"Barshtein G, Arbell D, Gural A, et al. Distribution of red blood cells deformability: study on density-separated cell subpopulations. Coll Interf. 2024;8(4):47.","journal-title":"Coll Interf"},{"issue":"1","key":"3602_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12933-024-02453-2","volume":"23","author":"I Ebenuwa","year":"2024","unstructured":"Ebenuwa I, Violet PC, Tu H, et al. Altered RBC deformability in diabetes: clinical characteristics and RBC pathophysiology. Cardiovasc Diabetol. 2024;23(1):370.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3602_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3121\/cmr.4.3.236","volume":"4","author":"F Aslinia","year":"2006","unstructured":"Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006;4(3):236\u201341.","journal-title":"Clin Med Res"},{"issue":"4","key":"3602_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/ijlh.12158","volume":"36","author":"B Toprak","year":"2014","unstructured":"Toprak B, Yalc\u0131n HZ, Colak A. Vitamin\u00a0B12 and folate deficiency: should we use a different cutoff value for hematologic disorders? Int J Lab Hematol. 2014;36(4):409\u201314.","journal-title":"Int J Lab Hematol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03602-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:13:48Z","timestamp":1785518028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03602-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3602"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03602-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Keita Teruya, Aya Maruyama, and Yuko Mitobe are employees of Torii Pharmaceutical Co., Ltd. Hirokazu Honda is a scientific advisor for Astellas Pharma, Bayer Yakuhin, Kyowa Kirin, Mitsubishi Tanabe Pharma, and Torii Pharmaceutical, and has received research funding from Chugai Pharmaceutical, Kyowa Kirin, and Otsuka Pharmaceutical, as well as lecture fees from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Mitsubishi Tanabe Pharma, and Torii Pharmaceutical.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and informed consent were waived as the patient records had already been anonymized and de-identified in accordance with Japan\u2019s Ethical Guidelines for Medical and Biological Research Involving Human Subjects. This study was conducted in accordance with the ethical principles of the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}